DENDRIGENE

pharmaceuticals, namely highly branched polymers conjugated with genetic and/or target directors and/or kits thereof for use in treating genetic disorders, cancer and other diseases which respond to genetic manipulation, in humans and animals

custom manufacturing of chemicals for use by others

product development of chemicals for others